XYIGF yields 3.87% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, XYIGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of XYIGF + PFE for your $10,000?
Xinyi Glass Holdings Limited, an investment holding company, produces and sells automobile, construction, float, and other glass products for commercial and industrial applications. The company operates through three segments: Float Glass, Automobile Glass, and Architectural Glass. It is also involved in the manufacturing and sale of automobile rubber and plastic components, as well as electronic glass; trading of automobile glass; and research and trading of glass. In addition, the company offers logistic and related services; supply chain services; operates a wind farm for electricity generation; and manufactures automatic machines for solar glass factory and other glass related industries, as well as holds properties and car parks. The company serves automobile glass manufacturing; wholesale and distribution; automobile repair; motor vehicle manufacturing; curtain wall engineering and installing; architectural and furniture glass manufacturing; electronic and household appliances manufacturing; and float glass wholesale and distribution companies. It sells its products in approximately 140 countries and territories, including the People's Republic of China, Hong Kong, the United States, Canada, Australia, and New Zealand, as well as countries in Asia, the Middle East, Europe, Africa, and the Americas. The company was founded in 1988 and is headquartered in Kwun Tong, Hong Kong.
Full XYIGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.